Yarbrough Capital, LLC Axsome Therapeutics, Inc. Transaction History
Yarbrough Capital, LLC
- $2.44 Billion
- Q3 2024
A detailed history of Yarbrough Capital, LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Yarbrough Capital, LLC holds 5,054 shares of AXSM stock, worth $458,549. This represents 0.02% of its overall portfolio holdings.
Number of Shares
5,054
Previous 5,054
-0.0%
Holding current value
$458,549
Previous $406,000
11.82%
% of portfolio
0.02%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding AXSM
# of Institutions
325Shares Held
37.7MCall Options Held
912KPut Options Held
855K-
Rtw Investments, LP New York, NY4.19MShares$380 Million6.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4MShares$362 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$299 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA2.36MShares$214 Million34.46% of portfolio
-
Bvf Inc San Francisco, CA1.05MShares$94.9 Million2.99% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $3.89B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...